Adagene Inc. (FRA:978)
Germany · Delayed Price · Currency is EUR 3.340
+0.060 (1.83%)
Last updated: Aug 26, 2026, 3:25 PM CET
Adagene Market Cap
Adagene has a market cap or net worth of €221.87 million as of August 26, 2026. Its market cap has increased by 134.05% in one year.
Market Cap
221.87M
Enterprise Value
131.52M
Revenue
8.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.34
ChartMarket Cap Chart
Since February 9, 2021, Adagene's market cap has decreased from 1.05B to 221.87M, a decrease of -78.79%. That is a compound annual growth rate of -24.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 221.87M | 192.45% |
| Dec 31, 2025 | 75.87M | -10.84% |
| Dec 31, 2024 | 85.09M | 11.10% |
| Dec 29, 2023 | 76.59M | 42.27% |
| Dec 30, 2022 | 53.84M | -82.59% |
| Dec 31, 2021 | 309.16M | -70.44% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 69.60M |
| 2invest AG | 43.64M |
| Biomark Diagnostics | 29.82M |
| Vidac Pharma Holding | 22.72M |
| co.don AG | 360.77K |
| Paion AG | 342.42K |
| bioXXmed AG | 231.09K |